Evidence map›Paper›PMID 41828133›Full record

ArticleMaterials (Basel, Switzerland)2026

Fermentative Production of 1,3-Propanediol from Glycerol in a Membrane Bioreactor with Microfiltration Membranes: A Feasibility Study.

Wirginia Tomczak, Marek Gryta

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wirginia TomczakFaculty of Chemical Technology and Engineering, Bydgoszcz University of Science and Technology, 3 Seminaryjna Street, 85-326 Bydgoszcz, Poland.ORCID 0000-0002-6320-5711
Marek GrytaFaculty of Chemical Technology and Engineering, West Pomeranian University of Technology in Szczecin, Piastów Ave. 17, 70-310 Szczecin, Poland.ORCID 0000-0002-2714-7104

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In biotechnological processes, value-added products such as 1,3-propanediol (1,3-PD) are obtained in multi-component mixtures consisting of by-products, nutrient medium, bacterial cells and residual substrate. For this reason, separation to obtain the main product with the use of various techniques is economically unprofitable. Contrary, membrane bioreactors (MBRs) ensure several benefits and may play a crucial role in reducing the operating costs. The main objective of this work was to evaluate the feasibility of producing 1,3-PD in an MBR equipped with capillary polypropylene (PP) membranes for the MF (microfiltration) process. This article provides an in-depth examination of: (i) the yield of batch, fed-batch and fermentation in an MBR, (ii) the fouling mechanism during MF of fermentation broths, and (iii) PP membrane stability. It was found that performing the fermentation in an MBR allowed for production of 1,3-PD with the highest maximum yield, in the range of 0.48 g/g (0.58 mol/mol) to 0.59 g/g (0.72 mol/mol). Moreover, it was demonstrated that the significant decline of the MF process was mainly caused by the formation of a cake layer on the membrane surface. Nevertheless, the efficiency of the process was stable and ensured the high quality of the permeate. In addition, membrane cleaning with the use of 1% NaOH solution allowed to remove most of the foulants from the membrane surface. Despite repeated cleaning procedures, the membranes used in this work maintained their performance and efficiency. Hence, it can be concluded that the capillary polypropylene membranes for the MF process can be successfully used in MBR technology intended for the production of 1,3-PD by glycerol fermentation.

Indexed as

1,3-propanediolfermentationfoulingglycerolmembrane bioreactormicrofiltrationpolymeric membranesprocess yieldseparation

Identifiers

PMID41828133
PMCPMC12986384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.